Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

The global mammalian transient protein expression market is on a robust growth trajectory, projected to reach USD 762.34 million in 2024 and expand at a CAGR of 5.5% over the next decade, ultimately ...

Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...

Hyderabad (Telangana) [India], February 25 (ANI): Biological E Limited (BE) on Tuesday announced a strategic partnership with ...

Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.

Hyderabad-based Biological E. Limited (BE) is partnering with Danish firm Bavarian Nordic to expand access to the latter’s ...

Biological E (BE) has partnered with Bavarian Nordic to produce the Chikungunya vaccine, VIMKUNYA CHIKV VLP, for low and ...

The partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine ...

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...

Contract manufacturing agreement marks the first step in collaboration to establish supply for expanded access to chikungunya vaccines in low- and middle-income countries. COPENHAGEN, Denmark ...

Contract manufacturing agreement marks the first step in collaboration to establish supply for expanded access to chikungunya ...